+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjugate Vaccine"

Pneumovax 23 - Product Thumbnail Image

Pneumovax 23

  • Report
  • December 2018
  • 14 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • December 2024
  • 90 Pages
  • United States
From
From
From
UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • November 2024
  • 150 Pages
  • United Kingdom
From
Loading Indicator

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis. Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases. Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more